ALXO · Alx Oncology Holdings Inc
Market Cap
$276.55M
Shares
138.28M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-30 | 2026-06-29 | |
| 8-K | 2026-06-26 | 2026-06-25 | |
| 8-K | 2026-06-11 | 2026-06-10 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-08 | — | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| DEF 14A | 2026-04-20 | 2026-04-17 | |
| 8-K | 2026-04-13 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| 10-K | 2026-03-09 | 2025-12-31 | |
| 8-K | 2026-02-27 | — | |
| 8-K | 2026-01-30 | — | |
| 8-K | 2026-01-30 | — | |
| 8-K | 2026-01-21 | — | |
| 8-K | 2025-11-07 | — | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-09-12 | 2025-09-11 | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-12 | 2025-06-11 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-04-25 | 2025-04-23 | |
| DEF 14A | 2025-04-21 | — | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-03-06 | — | |
| 8-K | 2025-03-05 | 2025-02-28 | |
| 8-K | 2025-01-22 | 2025-01-16 | |
| 8-K | 2025-01-17 | 2025-01-16 | |
| 8-K | 2024-11-14 | 2024-11-08 | |
| 8-K | 2024-11-07 | 2024-11-05 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-10-04 | 2024-09-30 | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-08-06 | 2024-08-05 | |
| 8-K | 2024-06-17 | 2024-06-12 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| 8-K | 2024-05-02 | 2024-04-28 | |
| DEF 14A | 2024-04-22 | 2024-06-12 | |
| 10-K | 2024-03-07 | 2023-12-31 | |
| 8-K | 2024-03-07 | — | |
| 8-K | 2023-12-26 | 2023-12-22 | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-13 | — | |
| 8-K | 2023-10-06 | 2023-10-04 |
Showing 1–50 of 97 filings
Key facts
CIK
1810182
CUSIP
00166B105
13F (30d)
87 filings
87 filers
Visit website
Investor relations